The cost-effectiveness did not favor BMS group. it will be more beneficial to use DES in selective patient groups such as patients with diabetes or triple vessel disease.

• 但如果选择某些病患族群上使用涂药支架如糖尿病病患、三条血管阻塞或者使用不止一支支架处置上将更为有利。